Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the post-slider-and-carousel domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home1/qordata/stg.qordata.com/wp-includes/functions.php on line 6114
Disclosure, EFPIA, Pharma Compliance – qordata is a Data-Driven Compliance Platform Provider

Category: Disclosure, EFPIA, Pharma Compliance

Explore our library of blogs, insights, research papers, and more information on compliance in the life sciences industry.

The U.S Department of Health and Human Services (HHS) Office of Inspector General (OIG) issued the General Compliance Program Guidance (GCPG) on November 6th – 2023, for life sciences companies and other industry verticals. The GCPG follows an earlier announcement by the OIG, which was associated with modernizing compliance programs. It also contains a few […]

Newly appointed compliance professionals cannot be expected to understand the hassle of manually auditing 100% of commercial expense data. With countless expenses to track and monitor against compliance SOPs, ensuring strict adherence to company policies and accurate and legitimate expense recording. Living in a technologically advanced era, leveraging modern tools to ensure life sciences compliance […]

“Total penalties from compliance-related violations have crossed over $20 Billion since 2000.” Ethical and law-compliant interaction between life sciences companies and healthcare professionals (HCPs) is key to avoiding the risk of regulatory penalties, fines, and other consequences. Authorities such as the U.S Department of Justice (DOJ) and the Office of Inspector General (OIG) have made it clear […]

Regulatory expectations and board scrutiny are increasing, and there’s also a growing pressure on compliance leaders to oversee a wider range of compliance activities. Compliance management revolves around making sure that an organization adheres to applicable laws, regulations, and internal ethics, standards, and policies. However, effective compliance programs go beyond mere legal adherence. Effective compliance […]

“Failure to report complete and accurate CMS Open Payments data on time can result in Penalties and Fines of up to $1,150,000.” What is CMS Transparency Reporting? CMS transparency reporting, also known as CMS Open Payments, is a program established under the Affordable Care Act. Life sciences companies, including manufacturers and group purchasing organizations (GPOs), […]

CMS Open Payments reporting stands out as a critical aspect of life sciences compliance that demands meticulous attention from compliance officers. It serves as a transformative force, driving a paradigm shift in how stakeholders perceive transparency, integrity, and accountability within the industry. Open Payments Reporting builds trust and empowers patients with insights into the financial […]